{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:19:08Z","timestamp":1791483548456,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>As progress in medical interventions for childhood cancer advances, the number of survivors of childhood acute lymphoblastic leukemia (ALL) is rising. Presently, the overall survival rate exceeds 90% over a five-year period. With this upward trend in survival rates, there\u2019s a pressing necessity to investigate the enduring impacts of childhood cancer treatment. This systematic literature review focuses on the various long term cardiotoxic effects as a result of these treatments. The authors conducted a systematic review to identify studies that evaluated long-term cardiotoxic effects after anthracycline treatments among survivors of childhood ALL via PubMed search engine. Studies were included if ALL survivors were &lt;\u200921 years old at the time of ALL diagnosis, an average of &gt;\u20095 years post diagnosis and\/or &gt;\u2009120 weeks post completion of consolidation therapy, compared with a healthy control population, and in remission during the assessment. Compared to matched control populations, survivors of childhood ALL had significantly higher rates of diastolic dysfunction and congestive heart failure. Additionally, female sex, younger age at diagnosis, and higher total dosing of anthracyclines administered during treatment led to significantly higher measures of cardiotoxicity. This study underscores the long-term cardiotoxic effects in ALL survivors, primarily linked to anthracycline use. Inconsistent detection of diastolic dysfunction via conventional echocardiogram necessitates regular monitoring of subclinical markers to prevent premature cardiac aging and heart failure. Future research should prioritize longitudinal studies to assess cardiotoxic effects throughout adult ALL survivors\u2019 lifetimes, aiming to establish comprehensive follow-up guidelines.<\/jats:p>","DOI":"10.1186\/s40348-025-00196-y","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T04:15:49Z","timestamp":1751602549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A systematic review of long-term cardiotoxic effects of treatment in survivors of childhood acute lymphoblastic leukemia"],"prefix":"10.1186","volume":"12","author":[{"given":"Paige","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Whitney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coleton","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Beam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"196_CR1","doi-asserted-by":"publisher","first-page":"710163","DOI":"10.3389\/fonc.2021.710163","volume":"11","author":"ZN Al-Mahayri","year":"2021","unstructured":"Al-Mahayri ZN, AlAhmad MM, Ali BR (2021) Long-Term effects of pediatric acute lymphoblastic leukemia chemotherapy: can recent findings inform old strategies?? Front Oncol 11:710163 Published 2021 Oct 15","journal-title":"Front Oncol"},{"issue":"3","key":"196_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11899-011-0094-x","volume":"6","author":"JM Fulbright","year":"2011","unstructured":"Fulbright JM, Raman S, McClellan WS, August KJ (2011) Late effects of childhood leukemia therapy. Curr Hematol Malig Rep 6(3):195\u2013205","journal-title":"Curr Hematol Malig Rep"},{"key":"196_CR3","doi-asserted-by":"publisher","first-page":"598708","DOI":"10.3389\/fphar.2021.598708","volume":"12","author":"H Yu","year":"2021","unstructured":"Yu H, Qiu Y, Yu H et al (2021) Anthracycline induced cardiac disorders in childhood acute lymphoblastic leukemia: A Single-Centre, retrospective, observational study. Front Pharmacol 12:598708 Published 2021 Mar 29","journal-title":"Front Pharmacol"},{"issue":"4","key":"196_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/157340311799960645","volume":"7","author":"M Volkova","year":"2011","unstructured":"Volkova M, Russell R 3rd (2011) Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev 7(4):214\u2013220","journal-title":"Curr Cardiol Rev"},{"issue":"6","key":"196_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12410-012-9163-3","volume":"5","author":"TC Tan","year":"2012","unstructured":"Tan TC, Scherrer-Crosbie M (2012) Assessing the cardiac toxicity of chemotherapeutic agents: role of echocardiography. Curr Cardiovasc Imaging Rep 5(6):403\u2013409","journal-title":"Curr Cardiovasc Imaging Rep"},{"issue":"12","key":"196_CR6","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1080\/14779072.2016.1239528","volume":"14","author":"D Cardinale","year":"2016","unstructured":"Cardinale D, Cipolla CM (2016) Chemotherapy-induced cardiotoxicity: importance of early detection. Expert Rev Cardiovasc Ther 14(12):1297\u20131299","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"3","key":"196_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jaccao.2023.05.004","volume":"5","author":"PA Henriksen","year":"2023","unstructured":"Henriksen PA, Rankin S, Lang NN (2023) Cardioprotection in patients at high risk of Anthracycline-Induced cardiotoxicity: JACC: cardiooncology primer. JACC CardioOncol 5(3):292\u2013297 Published 2023 Jun 20","journal-title":"JACC CardioOncol"},{"issue":"7","key":"196_CR8","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097","journal-title":"PLoS Med"},{"issue":"7","key":"196_CR9","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/pbc.22637","volume":"55","author":"M Amigoni","year":"2010","unstructured":"Amigoni M, Giannattasio C, Fraschini D et al (2010) Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors. Pediatr Blood Cancer 55(7):1343\u20131347","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"196_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.recesp.2023.05.005","volume":"77","author":"C Fern\u00e1ndez-Avil\u00e9s","year":"2024","unstructured":"Fern\u00e1ndez-Avil\u00e9s C, Gonz\u00e1lez-Manzanares R, Ojeda S et al (2024) Diastolic function assessment with left atrial strain in long-term survivors of childhood acute lymphoblastic leukemia. Rev Esp Cardiol (Engl Ed) 77(1):60\u201368","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"4","key":"196_CR11","first-page":"451","volume":"18","author":"VW Li","year":"2017","unstructured":"Li VW, Cheuk DK, Cheng FW et al (2017) Myocardial stiffness as assessed by diastolic wall strain in adult survivors of childhood leukaemias with preserved left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging 18(4):451\u2013458","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"196_CR12","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/pbc.25492","volume":"62","author":"JR Christiansen","year":"2015","unstructured":"Christiansen JR, Kanellopoulos A, Lund MB et al (2015) Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 62(8):1437\u20131443","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"196_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11764-011-0186-6","volume":"6","author":"E Vandecruys","year":"2012","unstructured":"Vandecruys E, Mondelaers V, De Wolf D, Benoit Y, Suys B (2012) Late cardiotoxicity after low dose of anthracycline therapy for acute lymphoblastic leukemia in childhood. J Cancer Surviv 6(1):95\u2013101","journal-title":"J Cancer Surviv"},{"issue":"10","key":"196_CR14","doi-asserted-by":"publisher","first-page":"e77063","DOI":"10.1371\/journal.pone.0077063","volume":"8","author":"YF Cheung","year":"2013","unstructured":"Cheung YF, Yu W, Cheuk DK et al (2013) Plasma high sensitivity troponin T levels in adult survivors of childhood leukaemias: determinants and associations with cardiac function. PLoS ONE 8(10):e77063 Published 2013 Oct 21","journal-title":"PLoS ONE"},{"issue":"2","key":"196_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/10428194.2018.1474522","volume":"60","author":"D Chellapandian","year":"2019","unstructured":"Chellapandian D, Pole JD, Nathan PC, Sung L (2019) Congestive heart failure among children with acute leukemia: a population-based matched cohort study. Leuk Lymphoma 60(2):385\u2013394","journal-title":"Leuk Lymphoma"},{"key":"196_CR16","doi-asserted-by":"crossref","unstructured":"Xavier AC, Ge Y, Taub JW (2009) Down syndrome and malignancies: a unique clinical relationship: a paper from the 2008 william beaumont hospital symposium on molecular pathology. J Mol Diagn.;11(5):371\u2013380","DOI":"10.2353\/jmoldx.2009.080132"},{"key":"196_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000064682","volume":"98","author":"CM Schannwell","year":"2002","unstructured":"Schannwell CM, Schneppenheim M, Perings S et al (2002) Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 98:33\u201339","journal-title":"Cardiology"},{"issue":"12","key":"196_CR18","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/S0735-1097(02)01896-X","volume":"39","author":"G Schillaci","year":"2002","unstructured":"Schillaci G, Pasqualini L, Verdecchia P et al (2002) Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. J Am Coll Cardiol 39(12):2005\u20132011","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"196_CR19","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1002\/cncr.11274","volume":"97","author":"K Sorensen","year":"2003","unstructured":"Sorensen K, Levitt GA, Bull C, Dorup I, Sullivan ID (2003) Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study. Cancer 97(8):1991\u20131998","journal-title":"Cancer"},{"issue":"8","key":"196_CR20","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/cncr.23378","volume":"112","author":"CL Cox","year":"2008","unstructured":"Cox CL, Rai SN, Rosenthal D, Phipps S, Hudson MM (2008) Subclinical late cardiac toxicity in childhood cancer survivors: impact on self-reported health. Cancer 112(8):1835\u20131844","journal-title":"Cancer"},{"issue":"26","key":"196_CR21","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJM199506293322602","volume":"332","author":"SE Lipshultz","year":"1995","unstructured":"Lipshultz SE, Lipsitz SR, Mone SM et al (1995) Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332(26):1738\u20131743","journal-title":"N Engl J Med"},{"issue":"4","key":"196_CR22","first-page":"735","volume":"28","author":"S Balanehru","year":"1992","unstructured":"Balanehru S, Nagarajan B (1992) Intervention of adriamycin induced free radical damage. Biochem Int 28(4):735\u2013744","journal-title":"Biochem Int"},{"issue":"6","key":"196_CR23","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1096\/fj.03-0724rev","volume":"18","author":"S Fogli","year":"2004","unstructured":"Fogli S, Nieri P, Breschi MC (2004) The role of nitric oxide in anthracycline toxicity and prospects for Pharmacologic prevention of cardiac damage. FASEB J 18(6):664\u2013675","journal-title":"FASEB J"},{"issue":"7","key":"196_CR24","first-page":"1789","volume":"60","author":"OJ Arola","year":"2000","unstructured":"Arola OJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M, Voipio-Pulkki LM (2000) Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 60(7):1789\u20131792","journal-title":"Cancer Res"},{"issue":"1","key":"196_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1200\/JCO.1997.15.1.61","volume":"15","author":"K Sorensen","year":"1997","unstructured":"Sorensen K, Levitt G, Bull C, Chessells J, Sullivan I (1997) Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity. J Clin Oncol 15(1):61\u201368","journal-title":"J Clin Oncol"},{"issue":"2","key":"196_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1200\/JCO.1998.16.2.545","volume":"16","author":"K Nysom","year":"1998","unstructured":"Nysom K, Holm K, Lipsitz SR et al (1998) Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia. J Clin Oncol 16(2):545\u2013550","journal-title":"J Clin Oncol"},{"key":"196_CR27","unstructured":"Children\u2019s Oncology Group. Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers. Version 6.0. Monrovia, CA: Children\u2019s Oncology Group (2025) Accessed June 6, 2025. http:\/\/www.survivorshipguidelines.org\/pdf\/2025\/COG_LTFU_Guidelines_Comprehensive_v6.pdf"},{"issue":"10","key":"196_CR28","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jcmg.2022.03.022","volume":"15","author":"M Pak","year":"2022","unstructured":"Pak M, Kitai T, Kobori A et al (2022) Diagnostic accuracy of the 2016 Guideline-Based echocardiographic algorithm to estimate Invasively-Measured left atrial pressure by direct atrial cannulation. JACC Cardiovasc Imaging 15(10):1683\u20131691","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"196_CR29","doi-asserted-by":"publisher","first-page":"H315","DOI":"10.1152\/ajpheart.00142.2012","volume":"303","author":"G Carrick-Ranson","year":"2012","unstructured":"Carrick-Ranson G, Hastings JL, Bhella PS et al (2012) Effect of healthy aging on left ventricular relaxation and diastolic Suction. Am J Physiol Heart Circ Physiol 303(3):H315\u2013H322","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"196_CR30","doi-asserted-by":"publisher","first-page":"e0158302","DOI":"10.1371\/journal.pone.0158302","volume":"11","author":"RE Peverill","year":"2016","unstructured":"Peverill RE, Chou B, Donelan L, Mottram PM, Gelman JS (2016) Possible mechanisms underlying Aging-Related changes in early diastolic filling and long Axis Motion-Left ventricular length and blood pressure. PLoS ONE 11(6):e0158302 Published 2016 Jun 28","journal-title":"PLoS ONE"},{"issue":"6","key":"196_CR31","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/BF00685796","volume":"36","author":"NA Dobbs","year":"1995","unstructured":"Dobbs NA, Twelves CJ, Gillies H et al (1995) Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry. Cancer Chemother Pharmacol 36(6):473\u2013476","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"196_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/mpo.2950210704","volume":"21","author":"JH Silber","year":"1993","unstructured":"Silber JH, Jakacki RI, Larsen RL, Goldwein JW, Barber G (1993) Increased risk of cardiac dysfunction after anthracyclines in girls. Med Pediatr Oncol 21(7):477\u2013479. https:\/\/doi.org\/10.1002\/mpo.2950210704","journal-title":"Med Pediatr Oncol"},{"key":"196_CR33","doi-asserted-by":"crossref","unstructured":"G\u00f6zda\u015fo\u011flu S (2022) Infant Leukemia. In: Li W, ed. Leukemia. Exon Publications; https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK586204\/","DOI":"10.36255\/exon-publications-leukemia-infant-leukemia"}],"container-title":["Molecular and Cellular Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-025-00196-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40348-025-00196-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40348-025-00196-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:41:27Z","timestamp":1781606487000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40348-025-00196-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["196"],"URL":"https:\/\/doi.org\/10.1186\/s40348-025-00196-y","relation":{},"ISSN":["2194-7791"],"issn-type":[{"value":"2194-7791","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}